Respiratory syncytial virus bronchiolitis

Area of Science:

• Pediatrics
• Infectious Diseases
• Public Health

Background:

• Respiratory syncytial virus (RSV) bronchiolitis is a widespread respiratory illness causing small airway obstruction.
• It leads to substantial global morbidity and mortality, particularly in infants.
• Recurrent episodes and later development of asthma are potential long-term consequences.

Purpose of the Study:

• To review the clinical presentation and management of RSV bronchiolitis.
• To highlight preventive strategies and supportive care measures.
• To discuss long-term outcomes and emerging research.

Main Methods:

• Literature review of RSV bronchiolitis epidemiology, clinical features, and management.
• Synthesis of current preventive guidelines and treatment options.
• Analysis of risk factors for severe disease and long-term sequelae.

Main Results:

• Management focuses on prevention (hygiene, prophylaxis) and supportive care (hydration, nutrition, bronchodilators, steroids).
• Ribavirin may benefit severely ill patients or those with comorbidities.
• Avoiding environmental irritants like smoke improves recovery and reduces asthma risk.

Conclusions:

• RSV bronchiolitis requires a multifaceted approach involving prevention, supportive care, and environmental modification.
• Long-term monitoring for recurrent wheezing and asthma is important.
• Vaccine development is ongoing to combat this significant public health threat.